<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03442205</url>
  </required_header>
  <id_info>
    <org_study_id>TJDBPS03</org_study_id>
    <nct_id>NCT03442205</nct_id>
  </id_info>
  <brief_title>Treatment of Common Bile Duct Stones</brief_title>
  <official_title>Randomized Clinical Trial Investigating the Best Method of Treatment of Common Bile Duct Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ABSTRACT Introduction: Common bile duct (CBD) stone is a common clinical situation,
      especially in Asia area. Laparotomy and laparoscopic surgical procedure are often used for
      treatment. This study compares outcomes of different surgical procedures treating for the
      disease.

      Methods/design: This is a prospective, randomized, controlled multicenter trial with three
      treatment arms. One group underwent laparoscopic cholecystectomy (LC) + laparoscopic CBD
      exploration (LCBDE) + intraoperative endoscopic nasobiliary drainage ENBD + primary closure
      of CBD. The other underwent preoperative endoscopic retrograde cholangiopancreatography
      (ERCP) and subsequent LC and the third arm underwent laparoscopic cholecystectomy (LC) +
      laparoscopic CBD exploration (LCBDE) + primary closure of CBD. The duration of the entire
      trial is two years including prearrangement, follow-up and analyses.

      Discussion: Despite the fact plenty evidences provided by meta-analyses suggests that these
      approaches would appear comparable. It is hopeful to fully address which would be the better
      approach with this RCT design.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Adverse outcomes</measure>
    <time_frame>24 months</time_frame>
    <description>The patients developing complications/ the total patients</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Common Bile Duct Stone</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LC + LCBDE + ENBD + primary closure of CBD</intervention_name>
    <description>LC + LCBDE + ENBD + primary closure of CBD</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERCP technique + LC</intervention_name>
    <description>ERCP technique + LC</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LC + LCBDE + primary closure of CBD</intervention_name>
    <description>LC + LCBDE + primary closure of CBD</description>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with age between 18 - 80 years.

          -  Patients diagnosed with gallstones.

          -  Patients diagnosed with common bile duct stone by one of the three exam (US„ÄÅMRCP and
             CT).

          -  Patients diagnosed with common bile duct stone by intro-operative cholangiography or
             transcystic exploration.

          -  Patients understood the trial and accepted one of the three managements.

        Exclusion Criteria:

          -  Combined with Mirizzi syndrome and intrahepatic bile duct stones

          -  Previous EST/endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous
             transhepatic biliary drainage (PTBD)

          -  History of upper abdominal surgery.

          -  Serious heart, brain, lung, metabolic diseases history.

          -  Pregnant women.

          -  Unwillingness or inability to consent for the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renyi Qin, pHD</last_name>
    <role>Study Chair</role>
    <affiliation>Tongji Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hang Zhang, doctor</last_name>
    <phone>+8602783665314</phone>
    <email>okashiiyo@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renyi Qin, pHD</last_name>
      <phone>+8602783665314</phone>
      <email>ryqin@tjh.tjmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 17, 2018</study_first_submitted>
  <study_first_submitted_qc>February 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2018</study_first_posted>
  <last_update_submitted>February 28, 2018</last_update_submitted>
  <last_update_submitted_qc>February 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Renyi Qin</investigator_full_name>
    <investigator_title>Clinical professor</investigator_title>
  </responsible_party>
  <keyword>Common Bile Duct Stone;</keyword>
  <keyword>Laparoscopic Common Bile Duct Exploration;</keyword>
  <keyword>ERCP;</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calculi</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

